Related Experiment Videos
Summary
Paraneoplastic acrokeratosis Bazex, a skin condition, can manifest with psoriasiform lesions linked to esophageal cancer. Treatment of the underlying neoplasm and topical steroids helped regress the paraneoplastic syndrome.
Area of Science:
- Dermatology
- Oncology
- Pathology
Background:
- Acrokeratosis Bazex is a rare paraneoplastic syndrome often associated with squamous cell carcinomas, particularly of the lung and esophagus.
- This case highlights the association between esophageal neoplasm and psoriasiform skin lesions characteristic of Bazex syndrome.
Observation:
- A 67-year-old male presented with psoriasiform skin lesions, a hallmark of acrokeratosis Bazex, nine months post-esophageal cancer diagnosis.
- Clinical examination revealed significant hepatopathy without signs of metastasis.
- Histological, immunofluorescence, and ultrastructural analyses indicated capillaritis with both humoral and cellular inflammation.
Findings:
- Treatment of the esophageal neoplasm led to the regression of the paraneoplastic acrokeratosis.
- Adjunctive topical steroid therapy further aided in the regression of skin lesions.
- Despite treatment, a vitamin A deficiency persisted and could not be corrected through oral or parenteral vitamin A supplementation.
Implications:
- This case underscores the importance of recognizing acrokeratosis Bazex as a potential indicator of underlying malignancy, specifically esophageal cancer.
- The findings suggest that successful treatment of the primary neoplasm is crucial for managing the paraneoplastic syndrome.
- Further research into the pathogenetic mechanisms of Bazex syndrome, including the role of vitamin A metabolism, is warranted.